Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia

Area of Science:

• Cardiovascular Pathophysiology
• Neuroimmunology
• Oxidative Stress

Background:

• Hypomagnesemia is a common clinical disorder linked to diabetes, alcoholism, and diuretic use.
• Magnesium's role in cardiovascular health is critical, yet not fully understood.
• Dietary magnesium restriction in animal models offers insights into its cardiac effects.

Purpose of the Study:

• To investigate the hypothesis that magnesium deficiency induces substance P release, initiating cardiac damage.
• To elucidate the mechanisms by which substance P contributes to cardiovascular pathophysiology.
• To identify potential therapeutic targets for magnesium deficiency-related heart conditions.

Main Methods:

• Utilized animal models with dietary magnesium restriction (MgD).
• Reviewed key observations linking MgD to substance P (SP) release and subsequent events.
• Examined the effects of SP on inflammatory and endothelial cells via neurokinin-1 receptors.

Main Results:

• MgD promotes SP release, leading to inflammatory, oxidative, and nitrosative events.
• SP induces reactive oxygen and nitrogen species production, depleting antioxidants.
• SP enhances inflammatory cell infiltration and cardiovascular lesion formation, promoting cardiomyopathy.

Conclusions:

• Substance P release during MgD is a key initiator of cardiac dysfunction and injury.
• SP-mediated pathways contribute to heart disease in hypomagnesemia.
• Targeting SP pathways and utilizing antioxidants may offer novel therapeutic strategies beyond magnesium repletion.